FDA Panel to Vote on Future of Pain Drugs (Reuters)
Reuters - A U.S. advisory panel is set to
decide on Friday whether to recommend future sales of arthritis
drugs Vioxx, Celebrex and Bextra despite data linking the drugs
to higher risks of heart attacks.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace